title: Disruption of the actin cytoskeleton up-regulates iNOS expression in vascular smooth muscle cells.
abstract: Cytokines and bacterial lipopolysaccharide (LPS) induce the expression of inducible nitric oxide synthase (iNOS), resulting in the release of nitric oxide (NO) from vascular smooth muscle cells. We here demonstrated that disruption of F-actin formation by sequestration of G-actin with the toxin latrunculin B (Lat B) dramatically potentiated LPS-induced iNOS mRNA and protein expression. We also showed that Lat B enhanced interleukin-1beta- andbgr;- and TNFalpha-induced NO production. Lat B by itself had little or no effect on iNOS expression. Cytochalasin D also enhanced LPS-induced NO production. Lat B dose-dependently enhanced LPS-induced iNOS promoter activity but had no effect on the stability of iNOS mRNA. Staining of F-actin with nitrobenzoxadiazole (NBD)-phallacidin demonstrated that Lat B significantly impaired F-actin stress fiber formation. These data indicate that disruption of the actin cytoskeleton up-regulates cytokine-induced iNOS expression via transcriptional regulation. Further analysis of the signaling pathway from the actin cytoskeleton to iNOS expression may yield new insight into the mechanism of iNOS regulation.
authors.affiliation: Department of Endocrinology & Metabolism, Dokkyo University School of Medicine, Mibu, Tochigi, Japan. yhattori@dokkyomed.ac.jp
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Hattori
authors.forename: Kikuo
authors.initials: K
authors.lastname: Kasai
mesh_terms: D000199:Actins / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000494:pharmacology*; D002478:Cells, Cultured; D003599:Cytoskeleton / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D052247:Nitric Oxide Synthase Type II; D051381:Rats; D017208:Rats, Wistar; D013844:Thiazoles / Q000494:pharmacology*; D053778:Thiazolidines; D015854:Up-Regulation
chemical_list: D000199:Actins; D019086:Bridged Bicyclo Compounds, Heterocyclic; D013844:Thiazoles; D053778:Thiazolidines; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat; C037068:latrunculin B